Ramiah Investment Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$527K Buy
+1,454
New +$498K 0.4% 36
2025
Q2
Sell
-1,780
Closed -$555K 61
2025
Q1
$555K Buy
1,780
+238
+15% +$70.3K 0.53% 22
2024
Q4
$402K Buy
1,542
+7
+0.5% +$2.08K 0.37% 51
2024
Q3
$495K Sell
1,535
-1,079
-41% -$353K 0.47% 45
2024
Q2
$817K Buy
+2,614
New +$768K 0.8% 24
2022
Q4
Sell
-3,310
Closed -$746K 33
2022
Q3
$746K Sell
3,310
-215
-6% -$52.1K 4.51% 11
2022
Q2
$858K Sell
3,525
-797
-18% -$195K 0.7% 21
2022
Q1
$1.05M Sell
4,322
-35
-0.8% -$8.04K 0.72% 18
2021
Q4
$980K Buy
4,357
+1,113
+34% +$235K 0.66% 20
2021
Q3
$690K Buy
3,244
+75
+2% +$17.3K 0.49% 51
2021
Q2
$772K Sell
3,169
-13
-0.4% -$3.2K 0.55% 42
2021
Q1
$792K Buy
3,182
+675
+27% +$161K 0.6% 33
2020
Q4
$576K Buy
2,507
+156
+7% +$36K 0.48% 43
2020
Q3
$598K Sell
2,351
-1
-0% -$248 0.58% 35
2020
Q2
$555K Buy
+2,352
New +$537K 0.59% 37

Other funds holding AMGN

Ramiah Investment Group's AMGN Position: Q2 2026 in Review

Ramiah Investment Group opened a new position in Amgen (AMGN) in Q2 2026: 1,454 shares worth $527K. The stake represents 0.4% of the portfolio and ranks #36 among its holdings. This is a return to the name: Ramiah Investment Group previously reported a position in AMGN as recently as Q1 2025.

Ramiah Investment Group first reported a position in AMGN in Q2 2020 and has held it in 15 quarters since. The position peaked at $1.05M in Q1 2022. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Ramiah Investment Group held 1,454 shares of Amgen worth $527K as of Q2 2026.
  • Amgen was a new Ramiah Investment Group position in Q2 2026.
  • Amgen made up 0.4% of Ramiah Investment Group's portfolio in Q2 2026, its #36 holding.
  • Ramiah Investment Group first reported a position in Amgen in Q2 2020 and has held it in 15 quarters since.
  • Ramiah Investment Group's Amgen position peaked at $1.05M in Q1 2022.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Ramiah Investment Group's 13F filing for Q2 2026, filed 16 Jul 2026.